Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip

NCT03304379 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1650

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee
Osteoarthritis, Hip

Interventions

DRUG: Fasinumab
OTHER: Diclofenac
OTHER: Celecoxib
DRUG: Matching placebo

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]